Literature DB >> 3304049

Emergency liver transplantation for fulminant hepatitis.

H Bismuth, D Samuel, J Gugenheim, D Castaing, J Bernuau, B Rueff, J P Benhamou.   

Abstract

Orthotopic liver transplantation was done in 17 patients with fulminant hepatitis. The cause of the liver disease was infection with hepatitis B virus, or co-infection with hepatitis B virus and hepatitis D virus, or infection with hepatitis A virus in 6 patients; drug hepatotoxicity in 5; and indeterminate in 6. Grafts from incompatible blood groups, steatotic grafts, or reduced-size grafts were used in 5, 4, and 4 patients, respectively. Of the 17 patients, 5 died: 2 of early liver failure due to the poor quality of the graft, 1 presumably of accidentally transmitted acute infection with the human immunodeficiency virus, and 2 of decerebration occurring during or immediately after surgery. The 12 other patients were alive 2 to 15 months after transplantation.

Entities:  

Mesh:

Year:  1987        PMID: 3304049     DOI: 10.7326/0003-4819-107-2-337

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  35 in total

Review 1.  Fulminant hepatic failure. Clinical features, etiology, epidemiology, and current management.

Authors:  L Capocaccia; M Angelico
Journal:  Dig Dis Sci       Date:  1991-06       Impact factor: 3.199

Review 2.  Liver transplantation. A primer for practicing gastroenterologists. Part II.

Authors:  V J Dindzans; R R Schade; J S Gavaler; R E Tarter; D H Van Thiel
Journal:  Dig Dis Sci       Date:  1989-02       Impact factor: 3.199

3.  Liver transplantation for alcoholic liver disease: a consideration of reasons for and against.

Authors:  D H Van Thiel; J S Gavaler; R E Tarter; V J Dindzans; R D Gordon; S Iwatsuki; L Makowka; S Todo; A Tzakis; T E Starzl
Journal:  Alcohol Clin Exp Res       Date:  1989-04       Impact factor: 3.455

4.  Inhibition of nitric oxide production and the effects of arginine and Lactobacillus administration in an acute liver injury model.

Authors:  D Adawi; G Molin; B Jeppsson
Journal:  Ann Surg       Date:  1998-12       Impact factor: 12.969

5.  Support of the acutely failing liver: state of the art.

Authors:  A A Demetriou
Journal:  Ann Surg       Date:  1998-07       Impact factor: 12.969

Review 6.  Fulminant hepatic failure.

Authors:  R J Yanda
Journal:  West J Med       Date:  1988-11

7.  Liver transplantation for fulminant hepatic failure: experience with more than 200 patients over a 17-year period.

Authors:  Douglas G Farmer; Dean M Anselmo; R Mark Ghobrial; Hasan Yersiz; Suzanne V McDiarmid; Carlos Cao; Michael Weaver; Jesus Figueroa; Khurram Khan; Jorge Vargas; Sammy Saab; Steven Han; Francisco Durazo; Leonard Goldstein; Curtis Holt; Ronald W Busuttil
Journal:  Ann Surg       Date:  2003-05       Impact factor: 12.969

Review 8.  Controversies in patient selection for liver transplantation.

Authors:  E B Keeffe; C O Esquivel
Journal:  West J Med       Date:  1993-11

9.  Cadaveric liver transplantation for non-acetaminophen fulminant hepatic failure: a 20-year experience.

Authors:  Olivier Detry; Arnaud De Roover; Carla Coimbra; Jean Delwaide; Marie-France Hans; Marie-Hélène Delbouille; Joseé Monard; Jean Joris; Pierre Damas; Jacques Belaïche; Michel Meurisse; Pierre Honoré
Journal:  World J Gastroenterol       Date:  2007-03-07       Impact factor: 5.742

10.  Treatment of fulminant viral hepatic failure with prostaglandin E. A preliminary report.

Authors:  S B Sinclair; G A Levy
Journal:  Dig Dis Sci       Date:  1991-06       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.